Supreme Court Rejects Shkreli's Appeal
This is a news story, published by torontosun, that relates primarily to Martin Shkreli news.
Martin Shkreli news
For more Martin Shkreli news, you can click here:
more Martin Shkreli newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newstorontosun news
For more news from torontosun, you can click here:
more news from torontosunAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
Shkreli. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Turing Pharmaceuticals news, lifesaving drug news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Martin Shkrelitorontosun
•U.S. Supreme Court rejects appeal from ‘Pharma Bro’ Martin Shkreli
67% Informative
Martin Shkreli was once dubbed Pharma Bro ’ after jacking up the price of a lifesaving drug.
He appealed an order to return $64.6 million in profits he and his former company reaped.
His lawyers argued that the money went to his company rather than him personally.
Prosecutors said the company agreed in a settlement to pay $40 million .
VR Score
71
Informative language
71
Neutral language
67
Article tone
informal
Language
English
Language complexity
48
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links